Term
|
Definition
bactericidal and bacteriostatic prodrug (activated by peroxidase) then inhibits mycolic acid biosynthesis |
|
|
Term
|
Definition
|
|
Term
|
Definition
peripheral neuropathy, CNS issues, rheumatic syndrome, anemia |
|
|
Term
|
Definition
bactericidal RNA polymerase inhibitor |
|
|
Term
|
Definition
|
|
Term
|
Definition
hepatotoxicity red-orange fluids |
|
|
Term
|
Definition
bacteriostatic arabinoxyl transferase (EmbB) inhibitor - cell wall biosynthesis inhibitor |
|
|
Term
|
Definition
|
|
Term
|
Definition
optic neuritis, hyperurecimia, arthalgia |
|
|
Term
|
Definition
bactericidal prodrug (activated by pyrazinamidase) then acidification of cytoplasm |
|
|
Term
|
Definition
|
|
Term
|
Definition
hepatotoxicity, arthritis |
|
|
Term
|
Definition
bactericidal irreversible binding to 30S subunit of ribosome |
|
|
Term
aminoglycoside resistance |
|
Definition
dutations in ribosomes or rRNA |
|
|
Term
|
Definition
ototoxicity nephrotoxicity |
|
|
Term
|
Definition
bactericidal DNA gyrase inhibitor |
|
|
Term
fluoroquinolones resistance |
|
Definition
DNA gyrase mutations efflux pumps |
|
|
Term
|
Definition
|
|
Term
|
Definition
bactericidal d-alanine racemase and d-alanine d-alanine ligase inhibitor |
|
|
Term
|
Definition
mutations in target enzymes |
|
|
Term
|
Definition
|
|
Term
|
Definition
bacteriostatic prodrug (activaed by monooxygenase EtaA) then InhA inhibitors |
|
|
Term
|
Definition
|
|
Term
|
Definition
GI issues, hepatotoxicity |
|
|
Term
|
Definition
|
|
Term
cyclic peptides resistance |
|
Definition
identified with aminoglycosides |
|
|
Term
|
Definition
|
|
Term
p-aminosalicylic acid MOA |
|
Definition
bacteriostatic folic acid synthesis inhibitor |
|
|
Term
p-aminosalicylic acid ADE |
|
Definition
GI issues, hepatitis, anemia |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|